CAPSIATE

COC1=C(O)C=CC(COC(=O)CCCC\C=C\C(C)C)=C1

InChIKey=ZICNYIDDNJYKCP-SOFGYWHQSA-N

InChI=1S/C18H26O4/c1-14(2)8-6-4-5-7-9-18(20)22-13-15-10-11-16(19)17(12-15)21-3/h6,8,10-12,14,19H,4-5,7,9,13H2,1-3H3/b8-6+

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	1
Optical Activity	NONE

PubMed

Title	Date	PubMed
Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity.	2008-01-01	18172315
Downregulation of uncoupling protein-3 in vivo is linked to changes in muscle mitochondrial energy metabolism as a result of capsiate administration.	2007-05	17264228
Effect of topical application of capsaicin and its related compounds on dermal insulin-like growth factor-I levels in mice and on facial skin elasticity in humans.	2007-04	17307377
Immunosuppressive activity of capsaicinoids: capsiate derived from sweet peppers inhibits NF-kappaB activation and is a potent antiinflammatory compound in vivo.	2002-06	12115659

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:13:37 GMT 2025` Edited by `admin` on `Mon Mar 31 21:13:37 GMT 2025`
Record UNII	PX8I7HG5I3
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

6-NONENOIC ACID, 8-METHYL-, (4-HYDROXY-3-METHOXYPHENYL)METHYL ESTER, (6E)-

Preferred Name

English

CAPSIATE

Common Name

English

Code System Code Type Description

CAS

205687-01-0

Created by admin on Mon Mar 31 21:13:37 GMT 2025 , Edited by admin on Mon Mar 31 21:13:37 GMT 2025

PRIMARY

FDA UNII

PX8I7HG5I3

Created by admin on Mon Mar 31 21:13:37 GMT 2025 , Edited by admin on Mon Mar 31 21:13:37 GMT 2025

PRIMARY

EPA CompTox

DTXSID20174575

Created by admin on Mon Mar 31 21:13:37 GMT 2025 , Edited by admin on Mon Mar 31 21:13:37 GMT 2025

PRIMARY

PUBCHEM

9839519

Created by admin on Mon Mar 31 21:13:37 GMT 2025 , Edited by admin on Mon Mar 31 21:13:37 GMT 2025

PRIMARY